Dimethyl-[(4-methylphenyl)methyl]-[3-(tetradecanoylamino)propyl]azanium
C27H49N2O+ — CID 156846775
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dimethyl-[(4-methylphenyl)methyl]-[3-(tetradecanoylamino)propyl]azanium
Dimethyl-[(4-methylphenyl)methyl]-[3-(tetradecanoylamino)propyl]azanium (PubChem CID 156846775) has the molecular formula C27H49N2O+ and a molecular weight of 417.70 g/mol. Its IUPAC name is dimethyl-[(4-methylphenyl)methyl]-[3-(tetradecanoylamino)propyl]azanium.
Molecular Properties
| Compound Name | Dimethyl-[(4-methylphenyl)methyl]-[3-(tetradecanoylamino)propyl]azanium |
|---|---|
| PubChem CID | 156846775 |
| Molecular Formula | C27H49N2O+ |
| Molecular Weight | 417.70 g/mol |
| Exact Mass | 417.38 |
| IUPAC Name | dimethyl-[(4-methylphenyl)methyl]-[3-(tetradecanoylamino)propyl]azanium |
| SMILES | CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)Cc1ccc(C)cc1 |
| InChI | InChI=1S/C27H48N2O/c1-5-6-7-8-9-10-11-12-13-14-15-17-27(30)28-22-16-23-29(3,4)24-26-20-18-25(2)19-21-26/h18-21H,5-17,22-24H2,1-4H3/p+1 |
| InChIKey | SMCXRDOOPAAXSY-UHFFFAOYSA-O |
| XLogP | 6.78 |
| TPSA | 29.10 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 417.70 |
| LogP ≤ 5 | 6.78 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 1 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156846775 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.